CSIMarket
Company Name or Ticker Symbol
Search for oher Categories
 

Healthcare Sector

Major Pharmaceutical Preparations Industry  


Data by Company within Major Pharmaceutical Preparations Industry


  Marketcap Revenues (TTM) Net Income (TTM) Employees
Company (Millions) (Millions) (Millions) Number
Abbott Laboratories $ 86,630 $ 22,303 $ 1,503 77,000
Bristol Myers Squibb Co $ 91,074 $ 19,965 $ 4,827 25,000
Celgene Corp $ 108,792 $ 11,678 $ 2,140 6,012
Lilly Eli & Co $ 87,314 $ 21,585 $ 2,187 39,135
Johnson & Johnson $ 360,454 $ 72,174 $ 16,670 126,500
Merck & Co., Inc. $ 176,703 $ 39,929 $ 4,367 70,000
Mylan N.v. $ 20,585 $ 11,605 $ 533 25,000
Nivalis Therapeutics, Inc. $ 38 - $ -18 -
Pfizer Inc $ 202,353 $ 52,824 $ 7,246 78,300
Alexion Pharmaceuticals Inc $ 30,465 $ 3,412 $ 527 2,273
Dicerna Pharmaceuticals Inc $ 80 - $ -58 -
Concert Pharmaceuticals, Inc. $ 336 $ 0 $ -51 -
Aegerion Pharmaceuticals, Inc. $ 58 $ 197 $ -159 -
Agile Therapeutics Inc $ 132 - $ -29 -
Akebia Therapeutics, Inc. $ 515 - $ -154 -
Durect Corp $ 257 $ 15 $ -35 -
Dynavax Technologies Corp $ 387 $ 10 $ -108 -
Eagle Pharmaceuticals, Inc. $ 856 $ 237 $ 105 -
Egalet Corp $ 35 $ 20 $ -97 -
Eleven Biotherapeutics, Inc. $ 38 $ 1 $ 3 -
Enanta Pharmaceuticals Inc $ 725 $ 46 $ -13 -
Endocyte Inc $ 61 $ 0 $ -45 -
Epirus Biopharmaceuticals, Inc. $ 3 $ 1 $ -61 -
Epizyme, Inc. $ 719 - $ -120 -
Heron Therapeutics, Inc. $ 829 - $ -190 -
Natures Sunshine Products Inc $ 247 $ 340 $ 10 -
Nektar Therapeutics $ 3,474 $ 131 $ -198 -
Nephrogenex, Inc. $ 2 - $ -23 -
Newlink Genetics Corp $ 204 $ 33 $ -82 -
Northwest Biotherapeutics Inc $ 39 $ 0 $ -92 -
Novabay Pharmaceuticals, Inc. $ 61 $ 14 $ -12 -
Ohr Pharmaceutical Inc $ 24 - $ -29 -
Cambrex Corp $ 1,990 $ 501 $ 87 -
Raptor Pharmaceutical Corp $ 769 $ 110 $ -87 -
Imprimis Pharmaceuticals, Inc. $ 51 $ 22 $ -20 -
Tianyin Pharmaceutical Co., Inc. $ 4 $ 29 $ -4 -
Regeneron Pharmaceuticals Inc $ 58,521 $ 4,979 $ 979 -
Jazz Pharmaceuticals Plc $ 9,705 $ 1,528 $ 409 -
Amicus Therapeutics Inc $ 1,887 - $ -211 -
Impax Laboratories Inc $ 1,396 $ 783 $ -560 -
Lannett Co Inc $ 778 $ 663 $ -3 -
Alkermes Plc. $ 8,421 $ 804 $ -196 -
Ligand Pharmaceuticals Inc $ 2,800 $ 109 $ -3 -
Biomarin Pharmaceutical Inc $ 15,081 $ 1,184 $ -561 -
Lifevantage Corp $ 54 $ 202 $ 4 -
Alnylam Pharmaceuticals, Inc. $ 6,856 $ 59 $ -414 -
Pain Therapeutics Inc $ 158 - $ -12 -
Ampio Pharmaceuticals, Inc. $ 32 - $ -14 -
Array Biopharma Inc $ 1,266 $ 160 $ -112 -
Mei Pharma, Inc. $ 112 - $ 1 -
Omeros Corp $ 933 $ 46 $ -61 -
Opexa Therapeutics, Inc. $ 7 - $ -7 -
Biodel Inc $ 41 - $ -17 -
China Yct International Group, Inc. $ 18 $ 56 $ 10 -
Imagenetix Inc $ 0 $ 1 $ 0 -
Elite Pharmaceuticals Inc $ 111 $ 10 $ 25 -
Aoxing Pharmaceutical Company, Inc. $ 24 $ 30 $ -1 -
Palatin Technologies Inc $ 81 - $ -40 -
Vivus Inc $ 121 $ 136 $ 35 -
United Therapeutics Corp $ 5,617 $ 1,632 $ 395 -
Madrigal Pharmaceuticals, Inc. $ 4 - $ -26 -
Radius Health, Inc. $ 1,771 - $ -183 -
Immunocellular Therapeutics, Ltd. $ 1 - $ -22 -
Threshold Pharmaceuticals Inc $ 36 - $ -21 -
Shire Plc $ 100,363 $ 5,769 $ 1,135 -
Ibio, Inc. $ 28 $ 1 $ -15 -
Oramed Pharmaceuticals Inc. $ 109 - $ 7 -
Advaxis, Inc. $ 264 - $ -76 -
Protalex Inc $ 19 - $ -5 -
Immunogen Inc $ 531 $ 69 $ -141 -
Biodelivery Sciences International Inc $ 191 $ 42 $ 0 -
Therapeuticsmd, Inc. $ 1,072 $ 18 $ -90 -
Pernix Therapeutics Holdings, Inc. $ 31 $ 142 $ -109 -
Ocera Therapeutics, Inc. $ 25 - $ -28 -
Geron Corp $ 452 $ 6 $ -28 -
Chemocentryx, Inc. $ 479 - $ -38 -
Fibrocell Science, Inc. $ 53 - $ -23 -
Alimera Sciences Inc $ 95 $ 35 $ -29 -
Catalyst Pharmaceuticals, Inc. $ 257 - $ -18 -
Galectin Therapeutics Inc $ 69 - $ -20 -
Aveo Pharmaceuticals Inc $ 193 $ 4 $ -28 -
Sagent Pharmaceuticals, Inc. $ 715 $ 298 $ -25 -
Fortress Biotech, Inc. $ 181 $ 64 $ -69 -
Medicinova Inc $ 181 - $ -10 -
Arbutus Biopharma Corp $ 190 $ 1 $ -387 -
Acelrx Pharmaceuticals Inc $ 156 $ 17 $ -48 -
Horizon Pharma Plc $ 2,051 $ 997 $ -212 -
Mannkind Corp $ 123 - $ 134 -
Opko Health, Inc. $ 3,529 $ 1,227 $ -44 -
Sciclone Pharmaceuticals Inc $ 580 $ 166 $ 37 -
Arena Pharmaceuticals Inc $ 5,712 $ 121 $ -24 -
Sunesis Pharmaceuticals Inc $ 57 - $ -36 -
Provectus Biopharmaceuticals, Inc. $ 11 - $ -25 -
Corcept Therapeutics Inc $ 1,469 $ 93 $ 13 -
Sarepta Therapeutics, Inc. $ 2,273 - $ -123 -
Orexigen Therapeutics, Inc. $ 37 $ 48 $ -71 -
Cytokinetics Inc $ 664 $ 106 $ 16 -
Alexza Pharmaceuticals Inc. $ 21 - $ -14 -
Zogenix, Inc. $ 305 $ 22 $ -81 -
Cti Biopharma Corp. $ 95 $ 22 $ -76 -
Mast Therapeutics, Inc. $ 32 - $ -36 -
Achillion Pharmaceuticals Inc $ 563 - $ -62 -
Cumberland Pharmaceuticals Inc $ 112 $ 35 $ -2 -
Acadia Pharmaceuticals Inc $ 3,585 $ 33 $ -320 -
Spectrum Pharmaceuticals Inc $ 578 $ 140 $ -74 -
Endo International Plc $ 2,489 $ 1,779 $ -2,026 -
Medivation, Inc. $ 13,432 $ 1,027 $ -177 -
Amarin Corp Plcuk $ 1,067 $ 139 $ -78 -
Xenoport Inc $ 449 $ 48 $ -76 -
Arqule Inc $ 87 - $ -28 -
Akorn Inc $ 4,189 $ 1,102 $ 183 -
Tonix Pharmaceuticals Holding Corp. $ 16 - $ -30 -
Skystar Bio-pharmaceutical Co $ 1 $ 49 $ 11 -
Synthetic Biologics, Inc. $ 59 - $ -20 -
Reliv International Inc $ 19 $ 45 $ 0 -
Cormedix Inc. - $ 0 $ -20 -
Genvec Inc $ 16 $ 0 $ -8 -
Sucampo Pharmaceuticals, Inc. $ 671 $ 239 $ 27 -
Apricus Biosciences, Inc. $ 9 - $ 4 -
Generex Biotechnology Corp $ 4 - $ -52 -
Pharmathene, Inc $ 45 $ 5 $ 114 -
Prophase Labs, Inc. $ 36 $ 16 $ 43 -
Acura Pharmaceuticals, Inc $ 6 $ 7 $ -4 -
Keryx Biopharmaceuticals Inc $ 795 $ 43 $ -185 -
Rexahn Pharmaceuticals, Inc. $ 544 - $ -27 -
Xoma Corp $ 51 $ 2 $ -61 -
Biospecifics Technologies Corp $ 364 $ 27 $ 12 -
Insmed Inc $ 1,029 - $ -180 -
Mmrglobal, Inc. $ 0 $ 0 $ -3 -
Medicines Co $ 2,697 $ 142 $ -129 -
Cyclacel Pharmaceuticals, Inc. $ 7 - $ -10 -
Immune Pharmaceuticals Inc $ 19 - $ -38 -
Pacira Pharmaceuticals, Inc. $ 1,503 $ 280 $ -54 -
Oncosec Medical Inc $ 17 - $ -27 -
Synergy Pharmaceuticals, Inc. $ 873 - $ -203 -
Ani Pharmaceuticals Inc $ 562 $ 145 $ 4 -
Dipexium Pharmaceuticals, Inc. $ 15 - $ -17 -
Chembio Diagnostics, Inc. $ 80 $ 18 $ -15 -
Lexicon Pharmaceuticals, Inc. $ 1,710 $ 79 $ -144 -
Anacor Pharmaceuticals, Inc. $ 4,451 $ 85 $ -64 -
Anthera Pharmaceuticals Inc $ 10 - $ -55 -
Depomed Inc $ 649 $ 442 $ -95 -
Amag Pharmaceuticals Inc. $ 669 $ 562 $ -32 -
Rigel Pharmaceuticals Inc $ 267 $ 19 $ -67 -
Ironwood Pharmaceuticals Inc $ 2,461 $ 260 $ -121 -
Peregrine Pharmaceuticals Inc $ 1,058 $ 58 $ -28 -
Progenics Pharmaceuticals Inc $ 442 $ 69 $ 7 -
Abeona Therapeutics Inc. $ 338 $ 1 $ -22 -
Tapimmune Inc $ 26 - $ -16 -
World Health Energy Holdings, Inc. $ 45 - $ 0 -
Myos Rens Technology Inc. $ 9 $ 0 $ -4 -
Oragenics Inc $ 20 - $ -7 -
Taro Pharmaceutical Industries Ltd $ 4,908 - $ 0 -
Flamel Technologies Sa $ 428 $ 191 $ 10 -
Inergetics Inc $ 0 $ 1 $ -6 -
Ceres Ventures, Inc. - - $ 0 -
Sinovac Biotech Ltd $ 384 $ 67 $ 0 -
Actinium Pharmaceuticals, Inc. $ 54 - $ -28 -
Mabcure Inc. - - $ 0 -
Protect Pharmaceutical Corp $ 2 - $ 0 -
Prestige Brands Holdings, Inc. $ 2,839 $ 882 $ 69 -
Retrophin, Inc. $ 792 $ 138 $ -70 -
Rxi Pharmaceuticals Corp $ 13 - $ -12 -
Clovis Oncology, Inc. $ 4,063 - $ -324 -
Cempra, Inc. $ 215 $ 20 $ -111 -
Intellipharmaceutics International Inc. $ 41 - $ 0 -
Chimerix Inc $ 231 $ 6 $ -68 -
Merrimack Pharmaceuticals Inc $ 174 - $ -145 -
Verastem, Inc. $ 133 - $ -41 -
Siga Technologies Inc $ 166 $ 8 $ -55 -
China Pharma Holdings, Inc. $ 9 $ 15 $ -9 -
Juniper Pharmaceuticals Inc $ 53 $ 55 $ 6 -
Supernus Pharmaceuticals Inc $ 2,169 $ 228 $ 97 -
Tesaro, Inc. $ 6,802 $ 48 $ -433 -
Sage Therapeutics, Inc. $ 3,001 - $ -185 -
Ovascience, Inc. $ 53 $ 1 $ -75 -
Sibannac, Inc. $ 1 $ 1 $ 0 -
Kalobios Pharmaceuticals Inc $ 24 - $ -27 -
Regulus Therapeutics Inc. $ 59 $ 1 $ -81 -
Intercept Pharmaceuticals Inc $ 3,230 $ 46 $ -376 -
Vanda Pharmaceuticals Inc. $ 701 $ 150 $ -13 -
Valeant Pharmaceuticals International, Inc. $ 6,004 - $ -1,406 -
Celsion Corp $ 73 $ 1 $ -21 -
Athersys, Inc $ 160 $ 3 $ 0 -
Vertex Pharmaceuticals Inc $ 38,844 $ 2,019 $ 202 -
Ignyta, Inc. $ 386 - $ -116 -
Lipocine Inc. $ 92 - $ -17 -
Adamis Pharmaceuticals Corporation $ 96 $ 10 $ -19 -
Puma Biotechnology, Inc. $ 3,569 - $ -278 -
Biostar Pharmaceuticals, Inc. $ 4 - $ -6 -
Zoetis Inc. $ 30,714 $ 4,957 $ 854 -
Prothena Corp Plc $ 2,237 $ 1 $ -168 -
Tetraphase Pharmaceuticals Inc $ 258 $ 5 $ -90 -
Antriabio, Inc. $ 43 - $ -21 -
Genspera Inc $ 5 - $ -5 -
Insys Therapeutics, Inc. $ 825 $ 223 $ 5 -
Stemline Therapeutics Inc $ 213 $ 1 $ -44 -
Intra-cellular Therapies, Inc. $ 506 $ 0 $ -116 -
Mallinckrodt Plc $ 4,828 $ 3,277 $ 832 -
Portola Pharmaceuticals Inc $ 3,602 $ 32 $ -245 -
Aratana Therapeutics, Inc. $ 258 $ 42 $ -23 -
Evoke Pharma Inc $ 31 - $ -13 -
Novelion Therapeutics Inc. $ 36 - $ 0 -
Teva Pharmaceutical Industries Ltd $ 33,002 $ 22,723 $ 319 -
Mirati Therapeutics, Inc. $ 119 - $ -79 -
Ptc Therapeutics, Inc. $ 692 $ 90 $ -130 -
Esperion Therapeutics, Inc. $ 1,057 - $ -101 -
Heat Biologics, Inc. $ 14 - $ -13 -
Conatus Pharmaceuticals Inc. $ 149 - $ -26 -
Agios Pharmaceuticals Inc $ 2,377 $ 49 $ -241 -
Oncomed Pharmaceuticals Inc $ 124 $ 25 $ -98 -
Onconova Therapeutics, Inc. $ 13 $ 4 $ -21 -
Perrigo Co Plc $ 10,584 $ 5,564 $ -1,151 -
Dnib Unwind, Inc. $ 16 $ 15 $ -39 -
Five Prime Therapeutics Inc $ 789 $ 35 $ -75 -
Macrogenics Inc $ 590 $ 91 $ -66 -
Titan Pharmaceuticals Inc $ 41 $ 15 $ 4 -
Contravir Pharmaceuticals, Inc. $ 39 - $ -9 -
Ophthotech Corp. $ 91 $ 37 $ -200 -
Cymabay Therapeutics, Inc. $ 208 - $ -25 -
Scynexis Inc $ 44 $ 0 $ -27 -
Vaccinogen Inc $ 6 - $ -28 -
Karyopharm Therapeutics Inc. $ 369 $ 0 $ -112 -
Sophiris Bio Inc. $ 61 $ 0 $ -12 -
Cellectar Biosciences, Inc. $ 19 - $ -10 -
Phibro Animal Health Corp $ 1,540 $ 759 $ 64 -
Ultragenyx Pharmaceutical Inc. $ 2,834 - $ -261 -
Relypsa Inc $ 1,432 $ 36 $ -248 -
Kindred Biosciences, Inc. $ 160 - $ -23 -
Vital Therapies Inc $ 87 - $ -44 -
Cerulean Pharma Inc. - - $ -39 -
Emisphere Technologies Inc $ 30 $ 1 $ -2 -
Revance Therapeutics, Inc. $ 660 $ 0 $ -97 -
Versartis, Inc. $ 649 - $ -105 -
Recro Pharma, Inc. $ 143 $ 70 $ -32 -
Flexion Therapeutics Inc $ 756 - $ -79 -
Achaogen Inc $ 687 $ 39 $ -75 -
Argos Therapeutics Inc $ 12 $ 1 $ -64 -
Neurotrope, Inc. $ 34 - $ -11 -
Adamas Pharmaceuticals Inc $ 391 - $ -62 -
Xencor Inc $ 1,090 $ 85 $ 15 -
Tetralogic Pharmaceuticals Corp $ 0 - $ -41 -
Theravance Biopharma, Inc. $ 1,728 $ 33 $ -214 -
Trevena Inc $ 151 - $ -106 -
Pfenex Inc. $ 106 $ 60 $ 4 -
Ocular Therapeutix, Inc. $ 175 $ 2 $ -50 -
Aldeyra Therapeutics, Inc. $ 66 - $ -19 -
Amphastar Pharmaceuticals, Inc. $ 831 $ 252 $ 9 -
Minerva Neurosciences, Inc. $ 239 - $ -34 -
Catalent, Inc. $ 4,336 $ 1,991 $ 110 -
Globeimmune Inc $ 3 $ 6 $ -2 -
Contrafect Corp $ 52 - $ -26 -
Immune Design Corp. $ 304 $ 17 $ -54 -
Calithera Biosciences, Inc. $ 384 - $ -34 -
Futureworld Corp. $ 0 $ 1 $ -2 -
Aquinox Pharmaceuticals, Inc $ 341 - $ -39 -
Tokai Pharmaceuticals Inc $ 14 - $ -30 -
Corbus Pharmaceuticals Holdings, Inc. $ 269 $ 3 $ -25 -
Otonomy, Inc. $ 578 $ 1 $ -111 -
Loxo Oncology, Inc. $ 1,857 - $ -85 -
Marinus Pharmaceuticals Inc $ 40 - $ -27 -
Vitae Pharmaceuticals, Inc $ 605 $ 0 $ -45 -
Dermira, Inc. $ 1,039 - $ -90 -
Xenon Pharmaceuticals Inc. $ 58 $ 1 $ -27 -
Corium International, Inc. $ 222 $ 33 $ -38 -
Zafgen, Inc. $ 93 - $ -53 -
Propanc Biopharma, Inc. $ 5 - $ -9 -
Nexvet Biopharma Plc $ 79 - $ -20 -
Ardelyx, Inc. $ 258 - $ 0 -
Aduro Biotech, Inc. $ 904 $ 50 $ -84 -
Galmed Pharmaceuticals Ltd. $ 86 - $ 0 -
Gb Sciences Inc $ 28 - $ -10 -
Paratek Pharmaceuticals, Inc. $ 502 - $ -108 -
Kura Oncology, Inc. $ 181 - $ -28 -
Flex Pharma, Inc. $ 69 $ 1 $ -38 -
Kempharm, Inc $ 48 - $ -30 -
Neothetics, Inc. $ 7 - $ -10 -
Bellicum Pharmaceuticals, Inc. $ 311 $ 0 $ -76 -
Carbylan Therapeutics, Inc. $ 18 $ 0 $ -22 -
Inotek Pharmaceuticals Corporation $ 26 - $ -43 -
Zosano Pharma Corp $ 26 - $ -29 -
Fibrogen Inc $ 2,158 $ 178 $ -67 -
Colucid Pharmaceuticals, Inc. $ 747 - $ -25 -
Seres Therapeutics, Inc. $ 554 $ 22 $ -97 -
Glycomimetics Inc $ 270 - $ -50 -
Eyegate Pharmaceuticals Inc $ 14 $ 1 $ -14 -
Bellerophon Therapeutics, Inc. $ 42 - $ -36 -
Steadymed Ltd. $ 134 $ 1 $ 38 -
Blueprint Medicines Corp $ 1,735 $ 27 $ -85 -
Viking Therapeutics, Inc. $ 24 - $ -16 -
Collegium Pharmaceutical, Inc $ 367 - $ -102 -
Ritter Pharmaceuticals Inc $ 7 - $ -17 -
Zynerba Pharmaceuticals, Inc. $ 196 - $ -9 -
Fitlife Brands, Inc. $ 5 $ 27 $ 1 -
Chiasma, Inc $ 37 - $ -51 -
Pronai Therapeutics Inc $ 47 - $ 16 -
Baxalta Inc $ 31,754 $ 1,548 $ 145 -
Xbiotech Inc. $ 154 - $ -51 -
Jaguar Animal Health, Inc. $ 9 $ 1 $ -15 -
Catabasis Pharmaceuticals Inc $ 24 - $ -35 -
Global Blood Therapeutics, Inc. $ 1,056 - $ -89 -
Vtv Therapeutics Inc. $ 41 $ 0 $ -56 -
Neos Therapeutics, Inc. $ 128 $ 12 $ -88 -
Aimmune Therapeutics, Inc. $ 1,073 - $ -91 -
Peak Pharmaceuticals, Inc. $ 3 - $ 0 -
Aeglea Biotherapeutics, Inc. $ 47 $ 5 $ -23 -
Spring Bank Pharmaceuticals, Inc. $ 132 - $ -17 -
Moleculin Biotech, Inc. $ 34 - $ -3 -
Phaserx, Inc. $ 9 - $ -4 -
Reata Pharmaceuticals Inc $ 724 $ 50 $ -7 -
Clearside Biomedical, Inc. $ 226 $ 0 $ -10 -
Inspyr Therapeutics, Inc. $ 0 - $ 0 -
Novan, Inc. $ 68 - $ 0 -
Beyondspring Inc. $ 704 - $ 0 -
Uniqure N.v. $ 202 - $ 0 -
Sierra Oncology, Inc. $ 62 - $ 0 -
Kalvista Pharmaceuticals, Inc. $ 46 - $ 0 -
Albireo Pharma, Inc. $ 153 - $ 0 -
Avadel Pharmaceuticals Plc $ 423 - $ 0 -
Novelion Therapeutics Inc. $ 310 - $ 0 -
Aralez Pharmaceuticals Inc. $ 81 - $ 0 -
Axsome Therapeutics, Inc. $ 116 - $ 0 -
Beigene, Ltd. $ 36,667 - $ 0 -
Checkpoint Therapeutics, Inc. $ 199 - $ 0 -
Corvus Pharmaceuticals, Inc. $ 251 - $ 0 -
Gemphire Therapeutics Inc. $ 192 - $ 0 -
Kadmon Holdings, Inc. $ 123 - $ 0 -
Myovant Sciences Ltd. $ 1,682 - $ 0 -
Nabriva Therapeutics Ag $ 30 - $ 0 -
Patheon N.v. $ 5,111 - $ 0 -
Ra Pharmaceuticals, Inc. $ 331 - $ 0 -
Syros Pharmaceuticals, Inc. $ 478 - $ 0 -
Shineco, Inc. $ 44 - $ 0 -
Savara Inc. $ 21 - $ 0 -
Innocoll Holdings Plc $ 69 - $ 0 -
Avenue Therapeutics, Inc. $ 63 - $ 0 -
Tocagen Inc $ 24 - $ 0 -
Ovid Therapeutics Inc. $ 81 - $ 0 -
Major Pharmaceutical Preparations Industry $ 1,752,407 $ 332,041 $ 24,974 449,220
Earnings Earnings Earnings
Earnings Outlook increase
Looking into earnings estimates within the Major Pharmaceutical Preparations Industry in the current quarter, 33.33 % of companies, who provide earning guidance within Major Pharmaceutical Preparations Industry have increased their earnings outlook for the current fiscal year. But this falls short, as more corporations cut their earnings estimates.
Earnings Guidance unchanged
In the same quarter 22.22 % of companies, who provided earning outlook within Major Pharmaceutical Preparations Industry, have reiterated their earnings per share outlook for the current fiscal year unchanged.
Earnings Estimates decrease
Pessimism dominates within Major Pharmaceutical Preparations Industry, as most of the businesses cut their earnings guidance, staggering 44.44 % have revised down earnings outlook. Overall earnings expectations for the Major Pharmaceutical Preparations Industry were cut by %, to the annual earnings expectation of %.
Expected Eps Growth Eps Expectation Revision
n   %     Industry Expected EPS Growth
Total Ranking # Within Sector #
n   %   Industry Earnings Outlook Revision
Total Ranking # Within Sector #
Revenue Revenue Revenue
Sales Forecast increase
In the current quarter 33.33 % of companies, who have issued revenue expectation within Major Pharmaceutical Preparations Industry, have expressed their optimism, by increasing revenue outlook for the current fiscal year.
Sales Expectations unchanged
As even more corporations reiterate their sales projections, 66.67 % of businesses within Major Pharmaceutical Preparations Industry, while corporate executives do not expect any change of economic environment.
Sales Outlook decrease
In Major Pharmaceutical Preparations Industry, there were no sales guidance decreases
Expected Revenue Growth Revenue Expectation Revision
  %     Industry Expected Revenue Growth
Total Ranking # Within Sector #
  %   Industry Revenue Outlook Revision
Total Ranking # Within Sector #

Cardiovascular Segment
Revenues Income
24.1% -16.78% 377.7% -84.61%
Y/Y Q/Q Y/Y Q/Q

Neuroscience Segment
Revenues Income
- - - -
Y/Y Q/Q Y/Y Q/Q

Anti-Infective Segment
Revenues Income
14.75% -7.45% 23.14% -12.12%
Y/Y Q/Q Y/Y Q/Q

Respiratory Segment
Revenues Income
24.1% -16.78% 377.7% -84.61%
Y/Y Q/Q Y/Y Q/Q

Arthritis & Pain Segment
Revenues Income
24.3% 7.73% - -
Y/Y Q/Q Y/Y Q/Q

Urology Segment
Revenues Income
24.1% -16.78% 377.7% -84.61%
Y/Y Q/Q Y/Y Q/Q

Oncology Segment
Revenues Income
9.97% 1.68% - -
Y/Y Q/Q Y/Y Q/Q

Endocrine Segment
Revenues Income
-34.8% -30.47% - -
Y/Y Q/Q Y/Y Q/Q



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com